Mundipharma Announces its Digital Vision and Launches First Augmented Reality App to Help Asthma Sufferers ‘breatherite™’

Published on April 21, 2017

Mundipharma announces vision to focus on technology and providing game-changing healthcare solutions New vision exemplified…

Read More

MUNDIPHARMA ANNOUNCES STRATEGIC PARTNERSHIP WITH KOLON LIFE SCIENCE TO MARKET INVOSSATM IN KOREA

Published on April 10, 2017

Hailed as world’s first cell-medicated gene therapy for osteoarthritis Strategic marketing partnership to ensure reach…

Read More

Mundipharma Wins Approval for Antineoplastic Agent mundesine® as Treatment for Relapsed/Refractory Peripheral T-cell Lymphoma in Japan

Published on March 30, 2017

Japan first market to receive approval for treatment worldwide First oral PNP inhibitor to be…

Read More

Mundipharma helps fight common colds with introduction of BETADINE® Cold Defence

Published on February 22, 2017

A natural product with anti-viral effects further extends the BETADINE® product range A new treatment…

Read More

ARCHIVE

2017
2016
2015
2014

For all media enquiries, please contact:

Stephenie Vasko – Head of Communications Asia Pacific, Latin America, Middle East and Africa

Email Stephenie Vasko

(+65) 6303 9732

↓